Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jun;17(3):178-98.
doi: 10.1111/j.1755-5949.2009.00107.x. Epub 2010 May 18.

UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor

Affiliations
Review

UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor

Girolamo Calo' et al. CNS Neurosci Ther. 2011 Jun.

Abstract

Nociceptin/orphanin FQ (N/OFQ) controls several biological functions via selective activation of the N/OFQ peptide receptor (NOP). [(pF)Phe(4) Aib(7) Arg(14) Lys(15) ]N/OFQ-NH(2) (UFP-112) is an NOP receptor ligand designed using a combination of several chemical modifications in the same peptide sequence that increase NOP receptor affinity/potency and/or reduce susceptibility to enzymatic degradation. In the present review article, we summarize data from the literature and present original findings on the in vitro and in vivo pharmacological features of UFP-112. Moreover, important biological actions and possible therapeutic indications of NOP receptor agonists are discussed based on the results obtained with UFP-112 and compared with other peptide and nonpeptide NOP receptor ligands.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structure of nonpeptide NOP receptor agonists (top row) and antagonists (bottom row).
Figure 2
Figure 2
Primary structure of UFP‐112.
Figure 3
Figure 3
Typical tracing showing the kinetics of the inhibitory effects of equieffective concentrations of N/OFQ and UFP‐112 in the electrically stimulated mouse vas deferens.
Figure 4
Figure 4
Cumulative food intake following i.c.v. injection of different doses of N/OFQ (top panel) and UFP‐112 (bottom panel). Values are means ± sem of four separate experiments. *P< 0.05 versus control, according to ANOVA followed by Dunnett test for multiple comparisons. *indicates that all the data points of the relative treatment are statistically different from control.
Figure 5
Figure 5
Thirty‐minute food intake in rats treated with 0.05 nmol UFP‐112 i.c.v. at different times (1–8 h) before access to food. Values are means ± sem of four separate experiments. *P < 0.05 versus control, according to the Student's ttest for unpaired data.
Figure 6
Figure 6
Cumulative food intake following i.c.v. injection of 0.05 nmol UFP‐112 alone or with 2×20 nmol UFP‐101 (the first injection 15 min before and the second just before injection of UFP‐112). Values are means ± sem of four separate experiments. *P < 0.05 versus control, according to ANOVA followed by Dunnett test for multiple comparisons.

Similar articles

Cited by

References

    1. Jacoby E, Bouhelal R, Gerspacher M, Seuwen K. The 7 TM G‐protein‐coupled receptor target family. Chem Med Chem 2006;1:761–782. - PubMed
    1. Chung S, Funakoshi T, Civelli O. Orphan GPCR research. Br J Pharmacol 2008;153:S339–S346. - PMC - PubMed
    1. Lambert DG. The nociceptin/orphanin FQ receptor: A target with broad therapeutic potential. Nat Rev Drug Discov 2008;7:694–710. - PubMed
    1. Evans CJ, Keith DE, Jr ., Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science 1992;258:1952–1955. - PubMed
    1. Kieffer BL, Befort K, Gaveriaux‐Ruff C, Hirth CG. The delta‐opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 1992;89:12048–12052. - PMC - PubMed

Publication types